GlassScriptPhysician profile
Jeffrey S Johnson
NPI 1790952406
$13,869.24
in general payments reported to CMS, 2019-2025
28 companies · $3,096 in 2025
The $3,096 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,686 · 2020: $262 · 2021: $1,281 · 2022: $3,313 · 2023: $2,465 · 2024: $767 · 2025: $3,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,356 · Food and Beverage: $2,537 · Education: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,356.03 |
| Food and Beverage | $2,537.48 |
| Education | $433.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,497.61 | 2019-2025 | Comprehensive Shoulder System, Persona, Avitus Bone Harvester |
| Midsouth Orthopedics INC. | $3,841.07 | 2019-2024 | |
| Kci USA, INC. | $1,097.72 | 2019-2022 | |
| Arthrex, INC. | $642.16 | 2023 | |
| Kerecis Limited | $636.60 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Stryker Corporation | $164.57 | 2019-2023 | Iconix, Inspace |
| Horizon Therapeutics Plc | $100.11 | 2020-2023 | Krystexxa |
| Medical Device Business Services, INC. | $88.55 | 2024 | Motoband |
| Paratek Pharmaceuticals, INC. | $80.71 | 2019-2023 | Nuzyra |
| Arthrosurface Incorporated | $76.99 | 2019 | |
| Smith+Nephew, INC. | $76.71 | 2019-2025 | Renasys Go V2 Home, Allevyn Life L 15.4x15.4 Ctn10, Stravix |
| Djo, LLC | $61.00 | 2025 | Cmf |
| Heron Therapeutics, INC. | $57.36 | 2024 | Zynrelef |
| Innovation Technologies INC | $52.21 | 2022-2023 | Irrisept |
| Davol INC. | $49.04 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $48.09 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Vertex Pharmaceuticals Incorporated | $46.56 | 2024-2025 | |
| Anika Therapeutics, INC. | $35.84 | 2023 | Tactoset |
| Solventum Corporation | $33.41 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Acera Surgical, INC. | $28.21 | 2019-2020 | |
| Polynovo North America LLC | $25.64 | 2024 | Novosorb Btm |
| Abbvie INC. | $21.93 | 2024 | |
| Radius Health, INC. | $21.15 | 2019 | |
| Amgen INC. | $20.09 | 2024 | Prolia, Evenity |
| Baudax Bio INC. | $19.17 | 2020 | |
| Treace Medical Concepts, INC. | $17.54 | 2024 | |
| Kala Pharmaceuticals, INC. | $15.97 | 2021 | |
| Organogenesis INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.